Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction

Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction

By distinguishing between two types of neutralizing antibodies that either exhibit or lack antibody-dependent enhancement (ADE) activity, FcγRIIB and bivalent binding are shown to be required for ADE in SARS-CoV-2 infection.

Bibliographic Details
Main Authors:	Shuang Wang, Junchao Wang, Xiaojuan Yu, Wen Jiang, Shuo Chen, Rongjuan Wang, Mingzhu Wang, Shasha Jiao, Yingying Yang, Wenbo Wang, Huilin Chen, Ben Chen, Chunying Gu, Chuang Liu, An Wang, Min Wang, Gang Li, Cuicui Guo, Datao Liu, Jinchao Zhang, Min Zhang, Lan Wang, Xun Gui
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-03-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-022-03207-0

Similar Items

Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking
by: Luyan Liu, et al.
Published: (2022-07-01)

Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB
by: Ingrid Teige, et al.
Published: (2019-03-01)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
by: Xuemei He, et al.
Published: (2021-04-01)

Transmembrane domain dependent inhibitory function of FcγRIIB
by: Junyi Wang, et al.
Published: (2018-03-01)

SARS coronavirus has antibody-dependent enhancement (ADE) effect through the autologous antibodies against envelope spikes on Fcγ receptor expressing cells
by: Chun-Sheng Yeh, et al.
Published: (2016-05-01)

Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma
by: Vivian Changying Jiang, et al.
Published: (2022-04-01)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
by: Wen Jiang, et al.
Published: (2021-01-01)

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
by: Khiyam Hussain, et al.
Published: (2022-04-01)

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells
by: Jie Wei, et al.
Published: (2020-10-01)

The Complex Association of FcγRIIb With Autoimmune Susceptibility
by: J. Sjef Verbeek, et al.
Published: (2019-10-01)

447 Evaluation of efficacy and toxicity of human CD40 agonistic antibodies in C57BL/6-hCD40/hFcγRIIB HuGEMMTM
by: Lei Zheng, et al.
Published: (2023-11-01)

FcγRIIB is a T cell checkpoint in antitumor immunity
by: Clara R. Farley, et al.
Published: (2021-02-01)

The association between Fc gamma RIIb expression levels and chronic hepatitis B virus infection progression
by: Jinglan Jin, et al.
Published: (2021-12-01)

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
by: Shuang Wang, et al.
Published: (2020-11-01)

FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
by: Wei Hu, et al.
Published: (2019-07-01)

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
by: Alexander Rau, et al.
Published: (2021-01-01)

IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells
by: Mathias Gast, et al.
Published: (2018-08-01)

Porcine FcγRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection.
by: Songlin Qiao, et al.
Published: (2011-01-01)

Identification of candidate regulators of mandibular bone loss in FcγRIIB -/- Mice
by: Nithidol Sakunrangsit, et al.
Published: (2021-09-01)

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
by: Wen Jiang, et al.
Published: (2022-07-01)

C-reactive protein impairs immune response of CD8+ T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma
by: Jinxing Jiang, et al.
Published: (2023-10-01)

Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
by: Mansoor Karimifar, et al.
Published: (2021-12-01)

FcγRIIb-BCR coligation inhibits BCR signaling in chronic lymphocytic leukemia
by: Rosa Bosch, et al.
Published: (2020-03-01)

FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
by: Yu Ree Choi, et al.
Published: (2015-11-01)

Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone FcγRIIB-deficient mice
by: Mareki Ohtsuji, et al.
Published: (2018-02-01)

Correction to: Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
by: Mansoor Karimifar, et al.
Published: (2022-07-01)

IgG Fc engineering to modulate antibody effector functions
by: Xinhua Wang, et al.
Published: (2017-10-01)

FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation
by: Ashley N. Barlev, et al.
Published: (2022-09-01)

FcγRIIB modulates splenic germinal center response against immune subversion during acute influenza A virus infection
by: Yu-Hsuan Wu, et al.
Published: (2024-02-01)

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
by: Ricke, Darrell O.
Published: (2021)

Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signalling.
by: Emmanuel C Patin, et al.
Published: (2017-01-01)

Next generation Fc scaffold for multispecific antibodies
by: Bram Estes, et al.
Published: (2021-12-01)

DENV2 Pseudoviral Particles with Unprocessed Capsid Protein Are Assembled and Infectious
by: Jyoti Rana, et al.
Published: (2019-12-01)

Unveiling the hidden role of the interaction between CD36 and FcγRIIb: implications for autoimmune disorders
by: Chenfei He, et al.
Published: (2024-05-01)

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model.
by: Nithidol Sakunrangsit, et al.
Published: (2021-01-01)

Follicular Dendritic Cells Modulate Germinal Center B Cell Diversity through FcγRIIB
by: Cees E. van der Poel, et al.
Published: (2019-11-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer
by: Kodchakorn Mahasongkram, et al.
Published: (2023-12-01)

Antigen–antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function
by: Murali, TM, et al.
Published: (2024)

Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.
by: Elizabeth R Sprague, et al.
Published: (2006-06-01)